Related Experiment Video
Updated: Jul 26, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp
Rosaly Correa-de Araujo1, William J Evans2, Roger A Fielding3
1National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, USA.
Developing function-promoting therapies for aging and chronic disease requires multi-stakeholder collaboration, similar to Operation Warp Speed. Success hinges on well-designed clinical trials with clear endpoints and robust organization.
Area of Science:
- Gerontology and Rehabilitation Science
- Public Health Policy
- Biomedical Research
Background:
- Aging and chronic diseases cause significant functional limitations and physical disabilities.
- Developing effective function-promoting therapies is a critical public health priority.
Purpose of the Study:
- To discuss strategies for accelerating the development of function-promoting therapies.
- To identify key elements for successful clinical trials in this area.
Main Methods:
- An expert panel discussion was convened.
- Lessons learned from Operation Warp Speed were considered.
Main Results:
- Successful development of function-promoting therapies necessitates collaboration among diverse stakeholders.
- These stakeholders include academic researchers, government agencies (NIH, FDA), industry, and patient groups.
Conclusions:
- Well-designed clinical trials are essential, requiring precise definitions of indications, populations, and patient-important endpoints.
- Adequate resources and flexible organizational structures, mirroring Operation Warp Speed, are crucial for trial success.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Prodrugs
Prodrugs help overcome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...